Condition: TAVI(Transcatheter Aortic Valve Implantation) · Conduction Disorder · Aortic Stenosis · Sponsor: Clinical Hospital Center Rijeka
Prediction of conduction disorders (CDs) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) is an important and complex process with a significant impact on patient outcomes. The goal of this observational prospective trial is to investigate the role of pre-procedural values of systemic biomarkers of inflammation and fibrosis in the prediction of new-onset CDs and permanent pacemaker implantation (PPI) in patients undergoing the TAVI procedure.
This description comes directly from the study's public registry record.
Gordana Bačić, MD · +38551407320 · gordana.bacic@uniri.hr
Always discuss trial participation with your own doctor first.
| Clinical Hospital Center Rijeka | Rijeka, Croatia, Croatia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07201363